[1] Early Breast Cancer Trialists' Collaborative Group
(EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials[J]. Lancet,2011,378(9804):1707-1716.
[2] START Trialists' Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial[J]. Lancet Oncol,2008,9(4):331-341.
[3] Whelan TJ, Pignol JP, Levine MN, et al.Long-term results of hypofractionated radiation therapy for breast cancer[J]. N Engl J Med,2010,362(6):513-520.
[4] Smith BD, Bentzen SM, Correa CR, et al.Fractionation for whole breast irradiation: an American Society for Radiation Oncology(ASTRO) Evidence-Based Guideline[J]. Int J Radiat Oncol Biol Phys.2011,81(1):59-68.
[5] Haviland JS, Owen JR, Dewar JA, et al.The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials[J]. Lancet Oncol,2013,14(11):1086-1094.
[6] Smith BD, Bellon JR, Blitzblau R, et al.Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology(ASTRO) evidence-based guideline[J]. Pract Radiat Oncol,2018,8(3):145-152.
[7] Strnad V, Ott OJ, Hildebrandt G, et al.5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial[J]. Lancet,2016,387(10015):229-238.
[8] Correa C, Harris EE, Leonardi MC, et al.Accelerated partial breast irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement[J]. Pract Radiat Oncol,2017,7(2):73-79.
[9] EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials[J]. Lancet,2014,383(9935):2127-2135.
[10] Poortmans PM, Collette S, Kirkove C, et al.Internal mammary and medial supraclavicular irradiation in breast cancer[J]. N Engl J Med,2015,373(4):317-327.
[11] Whelan TJ, Olivotto IA, Parulekar WR, et al.Regional nodal irradiation in early-stage breast cancer[J]. N Engl J Med,2015,373(4):307-316.
[12] Thorsen LB, Offersen BV, Danø H, et al.DBCG-IMN: A population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J]. J Clin Oncol,2016,34(4):314-320.
[13] Wang SL, Fang H, Song YW, et al.Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial[J]. Lancet Oncol,2019,20(3):352-360.
[14] NCCN. Clinical Practice Guidelines in Oncology-Breast Cancer(2016 Version 1)[DB/OL]. 2015-11-18[2019-09-11].http://www.nccn.org.
[15] Hughes KS, Schnaper LA, Bellon JR, et al.Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343[J]. J Clin Oncol,2013,31(19):2382-2387.
[16] Kunkler IH, Williams LJ, Jack WJL, et al.Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial[J]. Lancet Oncol,2015,16(3):266-273.
[17] Solin LJ, Gray R, Hughes LL, et al.Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 Study[J]. J Clin Oncol,2015,33(33):3938-3944.
[18] Panchal H, Matros E.Current trends in postmastectomy breast reconstruction[J]. Plast Reconstr Surg,2017,140(5S Advances in Breast Reconstruction): 7S-13S.
[19] 修秉虬, 郭瑢, 杨犇龙, 等. 中国乳腺癌术后乳房重建手术横断面调查研究[J]. 中华肿瘤杂志,2019,41(7): 546-551.
[20] Jagsi R, Momoh AO, Qi J, et al.Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction[J]. J Natl Cancer Inst,2018,110(2). doi: 10.1093/jnci/djx148.
[21] Vargo JA, Beriwal S.RTOG Chest Wall Contouring Guidelines for post-mastectomy radiation therapy: Is it evidence-based?[J]. Int J Radiat Oncol Biol Phys,2015,93(2):266-267.
[22] Offersen BV, Boersma LJ, Kirkove C, et al.ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer[J]. Radiother Oncol,2015,114(1):3-10.
[23] Nissen HD, Yates ES, Andersen K, et al.PO-0918: Consensus on target volume delineation and treatment planning strategy for the DBCG RT Recon trial[J]. Radiother Oncol,2018,127:S492-S494.
[24] Kaidar-Person O, Vrou Offersen B, Hol S, et al.ESTRO ACROP consensus guideline for target volume delinea-tion in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer[J]. Radiother Oncol,2019,137:159-166.
